Table 4.
UNIVARIABLE | MULTIVARIABLE | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
PPI (TVC) | 1.87 | 1.14–3.06 | 0.012 | 1.82 | 1.11–2.99 | <0.001 |
PVL (TVC) | 0.29 | 0.04–2.14 | 0.230 | |||
SAA | 1.06 | 0.64–1.73 | 0.814 | |||
TAVI vs. SuRD-AVR | 1.53 | 1.02–2.03 | 0.040 | 1.74 | 1.12–2.71 | 0.013 |
PAPs > 30 mmHg | 1.06 | 0.69–1.64 | 0.771 | |||
LVEF < 35% | 0.81 | 0.19–3.35 | 0.780 | |||
III stage CKD | 3.39 | 1.67–6.89 | <0.001 | 3.45 | 1.70–7.01 | <0.001 |
PPI: Permanent Pacemaker Implantation, TVC: Time Varying Covariate; SAA: Small Aortic Annulus echocardiographic annulus < 21 mm; PAP: Pulmonary Artery Pressure; LVEF: Left Ventricular Ejection fraction; CKD: Chronic Kidney Disease. Statistically significant p-values (p < 0.05) are highlighted in bold.